바이오의약품 발효 시스템 시장 : 기회와 전략(-2033년)

Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033

US $ 5,000 ￦ 7,206,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,809,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,413,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 바이오의약품 발효 시스템 시장은 2018년에 149억 3,090만 달러로 평가되었으며, 2023년까지 연평균 8.0% 이상 성장할 것으로 예상됩니다.

신규 생물학적 제제 개발 증가

역사적인 기간 동안, 새로운 생물학적 제제 개발의 증가는 바이오의약품 발효 시스템 시장의 성장을 뒷받침했습니다. 새로운 생물학적 제제 개발의 증가는 생명공학의 발전, 질병 메커니즘에 대한 이해의 증가, 표적 치료 및 개인화 치료에 대한 수요에 기인합니다. 바이오의약품 발효 시스템은 유전자 조작된 세포와 미생물을 배양하여 복잡한 치료용 단백질, 항체 및 백신의 대규모 합성을 가능하게 하는 생물학적 제제 제조에 사용됩니다. 예를 들어, 미국 의학도서관인 국립의학도서관에 따르면 2023년 미국 식품의약국(FDA)은 29개의 신규 화학제품(NCE)과 25개의 신규 생물학적 제제(NBE)를 포함한 55개의 신약을 승인했는데, 이는 2022년 37개의 승인에 비해 50% 증가한 수치입니다. 이에 따라 신규 생물학적 제제 개발이 증가하면서 바이오의약품 발효 시스템 시장의 성장을 견인했습니다.

목차

제1장 주요 요약

• 바이오의약품 발효 시스템 - 시장 매력과 거시경제 상황

제2장 목차

제3장 표목차

제4장 그림목차

제5장 보고서 구성

제6장 시장의 특징

• 일반적인 시장 정의
• 개요
• 바이오의약품 발효 시스템 시장 정의와 세분화
• 시장 세분화 : 제품별
  • 업스트림 제품
  • 다운스트림 제품
• 시장 세분화 : 용도별
  • 재조합 단백질
  • 단클론항체
  • 항생제
  • 프로바이오틱스
  • 기타
• 시장 세분화 : 최종사용자별
  • 바이오의약품 기업
  • CMO
  • CRO
  • 학술연구기관
  • 기타

제7장 주요 시장 동향

• 생산능력 증강을 위한 제조 시설 확장
• 발효 능력을 높이는 신기술 개발 센터
• 일회용 업스트림을 강화하기 위한 새로운 바이오리액터 개발

제8장 바이오의약품 발효 시스템 시장 : 거시경제 시나리오

• COVID-19의 영향 : 바이오의약품 발효 시스템 시장
• 우크라이나 전쟁의 영향 : 바이오의약품 발효 시스템 시장
• 고인플레이션의 영향 : 바이오의약품 발효 시스템 시장

제9장 세계의 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 성장 촉진요인, 2018-2023
  • 시장 성장 억제요인, 2018-2023
• 시장 성장 예측, 2023-2028, 2033F
  • 시장 성장 촉진요인, 2023-2028
  • 시장 성장 억제요인, 2023-2028

제10장 세계의 바이오의약품 발효 시스템 시장 : 세분화

• 세계의 바이오의약품 발효 시스템 시장 : 제품별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 바이오의약품 발효 시스템 시장 : 용도별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 바이오의약품 발효 시스템 시장 : 최종사용자별, 실적과 예측, 2018-2023, 2028F, 2033F

제11장 바이오의약품 발효 시스템 시장 : 지역·국가별 분석

• 세계의 바이오의약품 발효 시스템 시장 : 지역별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 바이오의약품 발효 시스템 시장 : 국가별, 실적과 예측, 2018-2023, 2028F, 2033F

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 상황과 기업 개요

• 기업 개요
• Danaher Corporation
• Thermo Fisher Scientific Inc
• F. Hoffman-La Roche Ltd
• Sartorius Stedim Biotech
• Getinge Group

제20장 기타 주요 기업과 혁신적 기업

• GE Healthcare Technologies Inc
• Lonza Group AG
• Agilent Technologies Inc
• Merck Co. & KGaA
• Charles River Laboratories
• Nova Biomedical Corporation
• Hamilton Company
• Eppendorf AG
• ZETA Holding GmbH
• Tecan Group Ltd
• Applikon Biotechnology
• Parr Instrument Company
• BioNet
• Cellexus Ltd
• Solaris Biotech S.r.l

제21장 경쟁 벤치마킹

제22장 경쟁 대시보드

제23장 주요 인수합병

제24장 기회와 전략

• 새로운 기회를 제공하는 국가
• 새로운 기회를 제공하는 부문
• 성장 전략

제25장 바이오의약품 발효 시스템 시장 : 결론과 제안

• 결론
• 제안

제26장 부록

ksm

영문 목차

영문목차

Biopharmaceutical fermentation systems are specialized equipment and processes used to cultivate microorganisms or cells for the production of biopharmaceuticals. Biopharmaceutical fermentation systems are critical in scaling up from laboratory research to commercial production, enabling the efficient and safe manufacture of complex biopharmaceutical products.

The biopharmaceutical fermentation systems market consists of sales, by entities (organizations, sole traders and partnerships), of biopharmaceutical fermentation systems that are used in the production of a wide range of biologic drugs and therapies.

The global biopharmaceutical fermentation systems market was valued at $14,930.9 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.

Rise In Development Of Novel Biologics

During the historic period, the rise in development of novel biologics supported the growth of the biopharmaceutical fermentation systems market. The rise in development of novel biologics can be attributed to advancements in biotechnology, increased understanding of disease mechanisms and the demand for targeted and personalized therapies. Biopharmaceutical fermentation systems are used in biologics production to cultivate genetically engineered cells or microorganisms, enabling the synthesis of complex therapeutic proteins, antibodies and vaccines on a large scale. For instance, according to the National Library of Medicine, a US-based medical library, in 2023, the US Food and Drug Administration (FDA) approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the rise in development of novel biologics drove the growth of the biopharmaceutical fermentation systems market.

New Technology Development Centers To Enhance Fermentation Capabilities

Companies in the biopharmaceutical fermentation systems market are developing new technology development centers to enhance fermentation capabilities. These centers facilitate the development of more effective and tailored fermentation technologies, thereby improving product development and manufacturing processes. For instance, in July 2023, Praj HiPurity Systems, an India-based company that provides end-to-end turnkey solutions for the biopharma industry, announced plans to establish a Technology Development Center to advance its fermentation technology capabilities. This initiative is driven by the growing demand for fermentation-based products in the pharmaceutical and biopharmaceutical industries. The center will focus on addressing customer challenges, especially in the complex injectable segment and will work on optimizing fermentation solutions to better meet industry needs.

The global biopharmaceutical fermentation systems market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 20.70% of the total market in 2023.

Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biopharmaceutical fermentation systems market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for biopharmaceutical fermentation systems? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical fermentation systems market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider biopharmaceutical fermentation systems market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application and by end-users.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the biopharmaceutical fermentation systems market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application and by end-users in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for biopharmaceutical fermentation systems providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Product: Upstream Products; Downstream Products
• 2) By Application: Recombinant Proteins; Monoclonal Antibodies; Antibiotics; Probiotics And Other Applications
• 3) By End-User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Academic Research Institutes; Other End-Users
• Companies Mentioned: Danaher Corporation; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Sartorius Stedim Biotech; Getinge Group
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biopharmaceutical fermentation systems indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Biopharmaceutical Fermentation Systems - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Biopharmaceutical Fermentation Systems Market Definition And Segmentations
• 6.4 Market Segmentation By Product
  • 6.4.1 Upstream Products
  • 6.4.2 Downstream Products
• 6.5 Market Segmentation By Application
  • 6.5.1 Recombinant Proteins
  • 6.5.2 Monoclonal Antibodies
  • 6.5.3 Antibiotics
  • 6.5.4 Probiotics
  • 6.5.5 Other Applications
• 6.6 Market Segmentation By End-Users
  • 6.6.1 Biopharmaceutical Companies
  • 6.6.2 Contract Manufacturing Organizations
  • 6.6.3 Contract Research Organizations
  • 6.6.4 Academic Research Institutes
  • 6.6.5 Other End-Users

7 Major Market Trends

• 7.1 Expansion Of Manufacturing Facility To Enhance Production Capacity
• 7.2 New Technology Development Centers To Enhance Fermentation Capabilities
• 7.3 Development Of New Bioreactors To Enhance Single-Use Upstream Operations

8 Biopharmaceutical Fermentation Systems Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The Biopharmaceutical Fermentation Systems Market
• 8.2 Impact Of The War In Ukraine On The Biopharmaceutical Fermentation Systems Market
• 8.3 Impact Of High Inflation On The Biopharmaceutical Fermentation Systems Market

9 Global Market Size And Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Biopharmaceutical Fermentation Systems Market Segmentation

• 10.1 Global Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Biopharmaceutical Fermentation Systems Market, Regional and Country Analysis

• 11.1 Global Biopharmaceutical Fermentation Systems Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Biopharmaceutical Fermentation Systems Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.6 Asia-Pacific Biopharmaceutical Fermentation Systems Market: Country Analysis
• 12.7 China Market
• 12.8 Summary
• 12.9 Market Overview
  • 12.9.1 Country Information
  • 12.9.2 Market Information
  • 12.9.3 Background Information
  • 12.9.4 Government Initiatives
  • 12.9.5 Regulations
  • 12.9.6 Regulatory Bodies
  • 12.9.7 Major Associations
  • 12.9.8 Taxes Levied
  • 12.9.9 Corporate Tax Structure
  • 12.9.10 Investments
  • 12.9.11 Major Companies
• 12.10 China Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 China Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Market
• 12.14 India Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 India Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Market
• 12.18 Japan Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Japan Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Japan Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Market
• 12.22 Australia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.24 Australia Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Market
• 12.26 Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Market
• 12.30 South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.32 South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major Companies
• 13.3 Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.6 Western Europe Biopharmaceutical Fermentation Systems Market: Country Analysis
• 13.7 UK Market
• 13.8 UK Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 UK Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.11 Germany Market
• 13.12 Germany Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 Germany Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.15 France Market
• 13.16 France Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 France Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.19 Italy Market
• 13.20 Italy Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Italy Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.23 Spain Market
• 13.24 Spain Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.26 Spain Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Major Companies
• 14.3 Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.6 Eastern Europe Biopharmaceutical Fermentation Systems Market: Country Analysis
• 14.7 Russia Market
• 14.8 Russia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.10 Russia Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 North America Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.6 North America Biopharmaceutical Fermentation Systems Market: Country Analysis
• 15.7 USA Market
• 15.8 Summary
• 15.9 Market Overview
  • 15.9.1 Country Information
  • 15.9.2 Market Information
  • 15.9.3 Background Information
  • 15.9.4 Government Initiatives
  • 15.9.5 Regulations
  • 15.9.6 Regulatory Bodies
  • 15.9.7 Major Associations
  • 15.9.8 Taxes Levied
  • 15.9.9 Corporate Tax Structure
  • 15.9.10 Investments
  • 15.9.11 Major Companies
• 15.10 USA Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 USA Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.12 USA Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Market
• 15.14 Canada Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.15 Canada Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.16 Canada Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 South America Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.6 South America Biopharmaceutical Fermentation Systems Market: Country Analysis
• 16.7 Brazil Market
• 16.8 Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.10 Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.5 Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Corporate Tax Structure
  • 18.2.10 Major Companies
• 18.3 Africa Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Danaher Corporation
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.3 Thermo Fisher Scientific Inc
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 F. Hoffman-La Roche Ltd
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Sartorius Stedim Biotech
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Getinge Group
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

• 20.1 GE Healthcare Technologies Inc
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Lonza Group AG
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 Agilent Technologies Inc
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 Merck Co. & KGaA
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Charles River Laboratories
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 Nova Biomedical Corporation
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 Hamilton Company
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 Eppendorf AG
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 ZETA Holding GmbH
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 Tecan Group Ltd
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 Applikon Biotechnology
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Parr Instrument Company
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 BioNet
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Cellexus Ltd
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 Solaris Biotech S.r.l
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Polaris Group Acquired Genovior Biotech
• 23.2 Lifera Acquired Saudi Biotechnology Manufacturing Co.
• 23.3 Croda International Plc Acquired Solus Biotech
• 23.4 Wacker Chemie Acquired ADL BioPharma

24 Opportunities And Strategies

• 24.1 Global Biopharmaceutical Fermentation Systems Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global Biopharmaceutical Fermentation Systems Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global Biopharmaceutical Fermentation Systems Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Biopharmaceutical Fermentation Systems Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer

관련자료